MedTrace Logo

Short, Animated Storytelling (SAS) for Addiction Stigma Reduction

NCT06705205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13397

Last updated 2025-09-03

No results posted yet for this study

Summary

Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery. Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale. Short, animated storytelling (SAS) is a novel health communication approach that scales easily because it can leapfrog barriers associated with language, culture, literacy and education levels. This study will investigate if a SAS video intervention can be used to reduce stigma, boost optimism and hope, and increasing empathy towards people with addiction. The study will also explore mechanisms of action of SAS interventions, by measuring the contribution of sound design to the effect of the intervention.

Conditions

  • Social Stigma Towards People With Addiction

Interventions

OTHER

SAS video

The intervention is a short, animated storytelling video, with soundtrack, aimed at reducing addiction stigma.

Sponsors & Collaborators

  • Alexander von Humboldt Association

    collaborator OTHER

  • Stanford Center for Digital Health

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Principal Investigators

  • Maya Adam, MD, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-03
Primary Completion
2025-08-22
Completion
2025-08-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06705205 on ClinicalTrials.gov